Assessment of the cytotoxic effects of the powder of Şalgam, a lactic acid fermented beverage based on black carrot, on breast carcinoma

Göster/ Aç
Tarih
2025Yazar
Şener, GöksuÖksüz Üçkayabaşı, Hale
Üçkayabaşı, Ali
Ilgaz, Nermin Seda
Ağırman, Bilal
Erten, Hüseyin
Pazarbaşı, Ayfer
Yılmaz, Mehmet Bertan
Üst veri
Tüm öğe kaydını gösterKünye
Şener G., Öksüz Üçkayabaşı H., Üçkayabaşı A., Ilgaz NS., Ağırman B., Erten H., Pazarbaşı A.,Yılmaz MB. Assessment of The Cytotoxic Effects of The Powder of Şalgam, a Lactic Acid Fermented Beverage Based on Black Carrot, on Breast Carcinoma. III. International Mineral Water Congress, 2025, 14-15.Özet
Recent advancements in phytotherapy have led to a surge in research fo cused on the therapeutic potential of plant extracts for the management
and supportive care of various medical conditions. Emerging research has
increasingly focused on the health benefits of traditional fermented foods
and beverages. Şalgam beverage has also recently attracted the attention of
researchers. It has gained popularity as a staple food not only in Türkiye’s
southern regions but also in other parts of the country (1). Şalgam is rich
in essential vitamins, minerals, antioxidants, phenolic compounds, and
anthocyanins. Epidemiological studies suggest that the consumption of
Şalgam may correlate with a reduced incidence of various diseases due to
their bioactive compounds (2). This study aimed to investigate the effica cy of Şalgam extract on breast cancer. We used MCF-7, a breast cancer cell
line, and NIH3T3, a healthy fibroblast cell line, as controls in the study. We
treated the cells, whose development we followed in a cell culture medium,
with Şalgam extract dissolved in different doses. Our study also included
a serum starvation group. The cytotoxic effects were quantified using the
3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay,
a standard method for evaluating cell viability. While NIH3T3 fibroblast
cells exhibited no significant differences in cytotoxicity when compared to
the control group post-treatment, a notable reduction in viability was ob served in MCF-7 breast cancer cells across all treatment groups, including
those supplemented with fetal bovine serum (FBS). The serum starvation
cohort demonstrated a pronounced decrease in cell viability in MCF-7 cells,
with the most significant effects noted in the stock solution treatment. These findings suggest that Şalgam extract has a discernible impact on the viability
of cancer cells and highlights its potential as a subject for further therapeutic
investigations.